Developing Drugs for Core Social and Communication Impairment in Autism

David J. Posey, Craig A. Erickson, Christopher J. McDougle

Research output: Contribution to journalReview article

47 Scopus citations

Abstract

There are many challenges to studying drug effects on core social and language impairment in autism. Drugs such as fenfluramine, naltrexone, and secretin do not appear to be efficacious for these core symptoms. Risperidone has led to improvement in some aspects of social relatedness when used to treat irritability in autism. More research is needed on the utility of selective serotonin reuptake inhibitors, cholinergic drugs, glutamatergic drugs, and oxytocin for core autistic symptoms.

Original languageEnglish (US)
Pages (from-to)787-801
Number of pages15
JournalChild and Adolescent Psychiatric Clinics of North America
Volume17
Issue number4
DOIs
StatePublished - Oct 1 2008

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Developing Drugs for Core Social and Communication Impairment in Autism'. Together they form a unique fingerprint.

  • Cite this